Pressure Biosciences Inc (PBIO) financial statements (2022 and earlier)

Company profile

Business Address 14 NORFOLK AVENUE
SOUTH EASTON, MA 02375
State of Incorp. MA
Fiscal Year End December 31
SIC 3826 - Laboratory Analytical Instruments (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments 193010381138117
Cash and cash equivalents 193010381138117
Receivables 131229475207281113
Inventory, net of allowances, customer advances and progress billings, including: 59369941609051,038
Inventory 5936187658589051,038
Other undisclosed inventory, net of allowances, customer advances and progress billings  (549)(672)(698)  
Prepaid expense    777
Intangible current assets  577663750  
Other undisclosed current assets 315185179163258214
Total current assets: 1,0571,0901,5141,3681,5901,490
Noncurrent Assets
Operating lease, right-of-use asset 22177
Property, plant and equipment 16566923920
Long-term investments and receivables 51717172026295
Long-term investments 51717172026295
Intangible assets, net (including goodwill) 490577663750  
Intangible assets, net (excluding goodwill) 490577663750  
Other undisclosed noncurrent assets   136   
Total noncurrent assets: 1,24572688679235315
TOTAL ASSETS: 2,3031,8162,4002,1601,6261,804
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities 3,2272,9252,2291,7591,6141,938
Accounts payable 772816659589407941
Accrued liabilities 2,0381,6581,113801957821
Employee-related liabilities 418451457369250176
Deferred revenue 4723
Debt 8,6817,8744,85312,9084,857252
Derivative instruments and hedges, liabilities     1,6853,296
Due to related parties 1668215   
Deferred revenue and credits263160141
Contract with customer, liability21
Other liabilities 6,3312,9501,2331,537  
Other undisclosed current liabilities 65  2609513,941
Total current liabilities: 18,51813,8538,35116,7269,2669,568
Noncurrent Liabilities
Long-term debt and lease obligation 156   530177
Long-term debt, excluding current maturities     530177
Operating lease, liability 156 
Liabilities, other than long-term debt 1918 578837
Deferred revenue and credits578837
Deferred revenue 1918
Other undisclosed noncurrent liabilities 527 174 126 
Total noncurrent liabilities: 7031817457743214
Total liabilities: 19,22013,8718,52516,78310,0099,782
Stockholders' equity
Stockholders' equity attributable to parent, including: (16,918)(12,055)(6,125)(14,623)(8,383)(7,978)
Common stock 42251713310230
Additional paid in capital 50,31344,26139,77730,83427,24526,037
Accumulated other comprehensive loss      (105)
Accumulated deficit (96,466)(78,942)(65,728)(55,349)(42,264)(39,557)
Warrants and rights outstanding 29,19222,59919,8079,8796,3255,417
Other undisclosed stockholders' equity attributable to parent 111111
Total stockholders' equity: (16,918)(12,055)(6,125)(14,623)(8,383)(7,978)
TOTAL LIABILITIES AND EQUITY: 2,3031,8162,4002,1601,6261,804

Income statement (P&L) ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Revenues 1,2211,8102,4582,2401,9761,798
Revenue, net2,2401,9761,798
Cost of revenue
(Cost of Goods and Services Sold)
 (583)(1,197)(1,280)(1,273)(834)(609)
Gross profit: 6386131,1789671,1421,189
Operating expenses (5,224)(7,616)(6,935)(6,888)(5,712)(5,363)
Other undisclosed operating income  1,1971,2801,273834609
Operating loss: (4,586)(5,806)(4,477)(4,647)(3,736)(3,565)
Nonoperating income (expense) (11,420)(6,073)(5,222)(6,069)1,029(3,850)
Interest and debt expense (11,920)(795)260185(5)(4,146)
Loss from continuing operations before income taxes: (27,926)(12,673)(9,439)(10,530)(2,712)(11,562)
Income tax benefit  217    
Loss before gain (loss) on sale of properties: (27,926)(12,456)(9,439)(10,530)(2,712)(11,562)
Other undisclosed net income (loss) 10,341(3,412)(14,034)   
Net loss: (17,585)(15,868)(23,473)(10,530)(2,712)(11,562)
Other undisclosed net income (loss) attributable to parent 1,5794,20713,774(185)54,146
Net loss attributable to parent: (16,006)(11,661)(9,699)(10,716)(2,707)(7,415)
Preferred stock dividends and other adjustments (1,518)(1,554)(679)  (23)
Other undisclosed net loss available to common stockholders, basic (61)(2,653)(13,095)   
Net loss available to common stockholders, diluted: (17,585)(15,868)(23,473)(10,716)(2,707)(7,438)

Comprehensive Income ($ in thousands)

9/30/2021
TTM
12/31/2020
12/31/2019
12/31/2018
12/31/2017
12/31/2016
12/31/2015
Net loss: (17,585)(15,868)(23,473)(10,530)(2,712)(11,562)
Comprehensive loss: (17,585)(15,868)(23,473)(10,530)(2,712)(11,562)
Other undisclosed comprehensive income (loss), net of tax, attributable to parent    (185)1104,041
Comprehensive loss, net of tax, attributable to parent: (17,585)(15,868)(23,473)(10,716)(2,602)(7,520)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: